May 26,2021

Digital chatbot Woebot lands FDA breakthrough designation to tackle postpartum depression

Digital mental health company Woebot Health has landed FDA Breakthrough Device Designation for its postpartum depression digital therapeutic, WB001. WB001 combines cognitive behavioral therapy and elements of interpersonal psychotherapy with the company’s conversational chatbot, Woebot, to deliver treatment directly through patients’ phones.

REGULATORY FDA

#chatbot

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 03,2021

BehaVR Partners With Reach’s National “Save Moms” Campaign to Improve Maternal Health in Vulnerable Populations

BehaVR, a digital therapeutics company that aims to liberate people from stress, anxiety and fear though the power of virtual reality, today announced a partnership with Save Moms — the national maternal mortality and morbidity prevention campaign directed by Reach, a 501(c)(3) global social impact organization — in support of expectant mothers in underserved communities. BehaVR will provide NurtureVR, a first-of-its-kind virtual reality program for expectant moms, to 5,000 low-income and otherwise marginalized families, along with a portion of sales proceeds, to support Reach’s efforts to provide maternal healthcare resources and education to expectant moms at higher risk for complications during and after pregnancy.

PRODUCT

#virtual reality

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 14,2021

The Role of Digital Mental Health in the Healthcare Journey

With more than 20,000 apps available to address myriad mental health challenges with varying degrees of support, it’s clear that digital mental health is experiencing a boom. But there seems to be little consensus regarding the true role that digital therapeutics can and should play within the greater context of a patient’s mental health care journey. In order to better articulate this role, we need to take a person-centered view and understand how digital therapeutics can help people not just in moments of need, but over the course of a lifetime.

View Analyst & Ambassador Comments
Go to original news
Jun 16,2021

Ksana Health Secures $2M Seed Round to Launch Advanced Mental Health Monitoring Platform

Ksana Health, a digital health company dedicated to revolutionizing behavioral healthcare and research through objective measurement and monitoring, announced today that it has raised $2M in seed funding led by Christian Angermayer’s re.Mind Capital. Separately, Ksana Health accepted an invitation from Anthem to join the Anthem Digital Incubator to pilot Ksana Health’s new digital health solution, Vira.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 04,2021

Sharecare Launches Evidence-Based Mental Wellness App

Sharecare, today announced the launch of Unwinding by Sharecare, a broad-based mental well-being app designed to help people better understand how their minds work, reduce their stress, and build healthier habits. Based on more than a decade of research by renowned neuroscientist and Sharecare’s executive medical director of behavioral health, Dr. Jud Brewer, Unwinding by Sharecare rounds out the digital health company’s suite of award-winning, clinically-validated digital therapeutics for behavioral health, which also includes Unwinding Anxiety, Eat Right Now, and Craving to Quit.

PRODUCT

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 08,2021

GPA Strengthens Mental Health Support For Players With SilverCloud Partnership

To mark World Mental Health Day (Sunday, October 10th), the Gaelic Players Association (GPA) is proud to announce details of a new partnership with SilverCloud Health. GPA members who sign up to the SilverCloud platform can access programmes on a wide variety of topics such as stress, money worries, alcohol, body image and more. These can be accessed on whatever device best suits the individual player’s needs and at a time most convenient to them.

COLLABORATION PARTNERSHIP

#institution

#virtual care

View Analyst & Ambassador Comments
Go to original news
Oct 08,2021

Limbix Presents Data Demonstrating Treatment with SparkRx Digital Therapeutic

Today, Limbix, a prescription digital therapeutic company developing mental health treatments for adolescents, announced positive results from a virtual randomized controlled trial of SparkRx, the company’s digital therapeutic for adolescents with symptoms of depression. For participants that completed the program as recommended (n = 83), SparkRx led to a statistically significant reduction in depression symptoms compared to an active control app (p = 0.023) and a 21% remission rate compared to a 4% remission rate for control at the end of treatment. Treatment response rates were 29% and 16%, respectively, for SparkRx and control. ‍

CLINICAL STUDY

#cbt

View Analyst & Ambassador Comments
Go to original news
Oct 18,2021

New Survey Shows Paradigm Shift in American Attitudes and Opinions About Mental Health Technology

Woebot Health today released the results of its proprietary survey, “A Paradigm Shift: Consumer Attitudes Toward Mental Health Technology in 2021.” The survey, which was designed to capture Americans’ attitudes and beliefs about their mental health, current mental health care habits and views on mental health technology, found that United States adults have favorable views about how technology, including mental health chatbots, can improve their mental health.

#chatbot

View Analyst & Ambassador Comments
Go to original news
Oct 21,2021

Sumitomo Dainippon Pharma inks deal for VR-based DTx with BehaVR

Sumitomo Dainippon Pharma Co. in Japan and US-based behavioural health firm BehaVR have signed definitive agreements to develop and market general wellness products and prescription digital therapeutics for the treatment of major mental health disorders. The companies initially collaborated in June last year. They jointly developed a wellness product for those experiencing "stressful, fearful and overwhelming" feelings in a social setting. Under their recently signed deals, Sumitomo will fund the development and commercialisation of three novel virtual reality-based therapies for the treatment of social anxiety disorder, generalised anxiety disorder and major depressive disorder. It pledged to pay BehaVR $5 million in upfront payments; up to $18 million in development milestone and R&D support payments, on top of commercial and operational support fees; and up to $140 million in milestone payments conditional upon commercial success.

COLLABORATION PARTNERSHIP

#r&d

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Oct 21,2021

Digital therapeutic 'HelloBetter Stress and Burnout' available to 50 million adults in Germany

Digital therapeutic course 'HelloBetter Stress and Burnout' has been approved by the Federal Institute for Drugs and Medical Devices as a Digital Health Application (DiGA). 'HelloBetter Stress and Burnout' is a digital health intervention for the treatment of stress, exhaustion, insomnia and depression. It is now integrated into Germany’s health system and can be offered as a course of treatment by therapists and doctors.

PRODUCT

#reimbursement

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to MENTAL HEALTH